These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7685309)

  • 1. [Endocrine therapies in breast cancer].
    Schnürch HG
    Gynakologe; 1993 Apr; 26(2):107-17. PubMed ID: 7685309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
    Graeff H; Jänicke F
    Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Palliative hormone therapy of advanced breast cancer].
    Schröder W
    Gynakologe; 1993 Apr; 26(2):131-6. PubMed ID: 7685310
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone receptor assessment for endocrine therapy in advanced breast cancer. Report of 28 cases.
    Chen PZ; Mei ZJ; Yao XY; Meng XQ
    Chin Med J (Engl); 1983 Oct; 96(10):751-3. PubMed ID: 6426873
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
    Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
    Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does obesity modify recurrence-free interval in breast cancer?].
    Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
    Pickartz H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid receptors in breast cancer.
    Cowan K; Lippman M
    Arch Intern Med; 1982 Feb; 142(2):363-6. PubMed ID: 7036926
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrine therapy of breast cancer].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV
    Sov Med; 1981; (12):54-9. PubMed ID: 7038903
    [No Abstract]   [Full Text] [Related]  

  • 18. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estrogen and progesterone receptors in breast cancer].
    Cohen Y; Borovik R
    Harefuah; 1985 Dec; 109(11):350-2. PubMed ID: 3912300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.